Vaginal Photobiomodulation for Chronic Pelvic Pain

Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexFemale
Age18+
SponsorSoLa Pelvic Therapy

About this trial

The goal of this clinical study is to determine if 8 treatments with photobiomodulation using near-infrared laser energy can help reduce chronic pelvic pain in women. Additionally, researchers want to determine if treatment with this type of energy can also alleviate pain with activities such as standing, sitting, urinating, having bowel movements and intercourse.

Eligibility criteria

Qualifiers

Age 18 years or older;

CPP for 3 months or longer;

Overall pelvic pain severity ≥4 in the last 7 days;

Pelvic muscle tenderness pain level ≥4.

Disqualifiers

Previous vaginal or vulvar laser therapy;

Receiving concurrent pelvic physical therapy;

Unable to tolerate vaginal/pelvic examination

Taking drugs that have heat- or light- sensitive contraindications;

Trial design

Treatments tested in this trial

  • SoLa Pelvic Therapy

Treatment groups

126 Participants
are divided into 2 treatment groups

Sponsors and collaborators

SoLa Pelvic Therapy

Lead sponsor

Uroshape LLC

Collaborator